Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP274770.RAf39orT6aOl-p0IWydTsVG2CZlEV_j5_lBB1H6H5Yhxg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP274770.RAf39orT6aOl-p0IWydTsVG2CZlEV_j5_lBB1H6H5Yhxg130_assertion type Assertion NP274770.RAf39orT6aOl-p0IWydTsVG2CZlEV_j5_lBB1H6H5Yhxg130_head.
- NP274770.RAf39orT6aOl-p0IWydTsVG2CZlEV_j5_lBB1H6H5Yhxg130_assertion description "[Hypermethylation of SFRP-1, DKK-3 and RUNX-3 was significantly associated with an increased risk of ESCC recurrence (P = 0.001, 0.003 and 0.001 for SFRP-1, DKK-3 and RUNX3, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP274770.RAf39orT6aOl-p0IWydTsVG2CZlEV_j5_lBB1H6H5Yhxg130_provenance.
- NP274770.RAf39orT6aOl-p0IWydTsVG2CZlEV_j5_lBB1H6H5Yhxg130_assertion evidence source_evidence_literature NP274770.RAf39orT6aOl-p0IWydTsVG2CZlEV_j5_lBB1H6H5Yhxg130_provenance.
- NP274770.RAf39orT6aOl-p0IWydTsVG2CZlEV_j5_lBB1H6H5Yhxg130_assertion SIO_000772 22171134 NP274770.RAf39orT6aOl-p0IWydTsVG2CZlEV_j5_lBB1H6H5Yhxg130_provenance.
- NP274770.RAf39orT6aOl-p0IWydTsVG2CZlEV_j5_lBB1H6H5Yhxg130_assertion wasDerivedFrom befree-20140225 NP274770.RAf39orT6aOl-p0IWydTsVG2CZlEV_j5_lBB1H6H5Yhxg130_provenance.
- NP274770.RAf39orT6aOl-p0IWydTsVG2CZlEV_j5_lBB1H6H5Yhxg130_assertion wasGeneratedBy ECO_0000203 NP274770.RAf39orT6aOl-p0IWydTsVG2CZlEV_j5_lBB1H6H5Yhxg130_provenance.